Use of organic compounds

Details for Australian Patent Application No. 2005224014 (hide)

Owner Novartis AG

Inventors Prescott, Margaret Forney; Dinboeck, Michaela; Feldman, David Louis; Zelenkofske, Steven

Agent Davies Collison Cave

Pub. Number AU-B-2005224014

PCT Pub. Number WO2005/089731

Priority 60/553,877 17.03.04 US; 60/557,358 29.03.04 US

Filing date 16 March 2005

Wipo publication date 29 September 2005

Acceptance publication date 16 July 2009

International Classifications

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/00 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

21 September 2006 PCT application entered the National Phase

  PCT publication WO2005/089731 Priority application(s): WO2005/089731

16 July 2009 Application Accepted

  Published as AU-B-2005224014

12 November 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005224017-Compositions and methods for reducing or preventing obesity

2005224012-Ophthalmic solution comprising sodium carboxymethylcellulose and hydroxypropylmethylcellulose